Opaleye Management Inc. recently boosted its investment in Eton Pharmaceuticals Inc. by acquiring 385,000 shares, reflecting a significant endorsement of Eton's market potential. Opaleye focuses on healthcare opportunities and holds a diverse portfolio valued at around $430 million.